10 out of 10
CMS builds this single score out of ten separate indicators drawn from claims. A provider earns a point for each indicator where it is not an outlier against national thresholds. This one scores at or near the top of the scale.
| Indicator | This provider | Read as |
|---|---|---|
| Visits near death | 97.9% | higher is better |
| Gaps in nursing visits | 62.9% | lower is better |
| Early live discharges | 9.2% | lower is better |
| Late live discharges | 41.3% | lower is better |
| Burdensome transitions, Type 1 | 10.4% | lower is better |
| Burdensome transitions, Type 2 | 0.7% | lower is better |
| Skilled nursing minutes on weekends | 6.0% | higher is better |
| Nurse care minutes per routine home care days | 14.50 min | higher is better |
| CHC/GIP provided | 0.5% | higher is better |
| Per-beneficiary spending | $14,248 | context, not a quality score |
Why live discharges matter. Hospice is for people expected to die within six months. A patient leaving hospice alive is sometimes the right outcome — they got better, or chose to resume curative treatment. But an unusually high rate can also indicate patients were enrolled who did not qualify, or were discharged when their care became expensive. CMS publishes early and late live-discharge rates for exactly this reason. Treat a high number as a question to ask, not a verdict.
★★★★☆ 4/5 family survey rating
| Survey question | Families answering "always" / top box | |
|---|---|---|
| Rated this hospice 9 or 10 out of 10 | 80.0% | |
| Would definitely recommend | 85.0% | |
| Family member treated with respect | 92.0% | |
| Got the emotional and spiritual support they wanted | 92.0% |
CAHPS Hospice Survey, completed by caregivers after the patient's death. Providers with too few responses are not scored.
| Practice | Patients receiving it | |
|---|---|---|
| Composite process measure (all seven care practices) | 100.0% | |
| Pain screening | 100.0% | |
| Pain assessment | 100.0% | |
| Shortness-of-breath screening | 100.0% | |
| Shortness-of-breath treatment | 100.0% | |
| Bowel regimen for patients on opioids | 100.0% | |
| Treatment preferences documented | 100.0% | |
| Beliefs and values addressed | 100.0% |
Share of patients for whom the provider documented each practice. These are process measures — they record whether something was done, not how well.
Average daily census: 247 patients.
| Owner | Role | Share | Associated since | CMS type flags |
|---|---|---|---|---|
| THE VISITING NURSE ASSOCIATION OF TEXAS | 5% OR GREATER DIRECT OWNERSHIP INTEREST | — | 10/28/2010 | — |
| ANA CURRY | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| ANDRES VILLAREAL | CORPORATE DIRECTOR | — | 8/3/2020 | — |
| CATHERINE ROSE | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| CECELIA COX | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| CHRIS CULAK | OPERATIONAL/MANAGERIAL CONTROL | — | 9/1/2025 | — |
| CHRIS SIMMONS | CORPORATE DIRECTOR | — | 5/26/2021 | — |
| CHRISTI MORROW | CORPORATE OFFICER | — | 5/21/2025 | — |
| CHRISTI MORROW | CORPORATE DIRECTOR | — | 5/25/2022 | — |
| CHRISTIAN EVANS | CORPORATE DIRECTOR | — | 5/25/2022 | — |
| DAVID OMAN | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| ELIZABETH ALLEN | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| ELIZABETH BEAUCHAMP | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| ELIZABETH GILL | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| FRANK NOEL | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| JAMES PETERS | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| JASON BENDER | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| JENNIFER AUSTIN | OPERATIONAL/MANAGERIAL CONTROL | — | 9/1/2025 | — |
| JOHN RICH | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| JORDAN BRAINERD | CORPORATE OFFICER | — | 5/22/2024 | — |
| JORDAN BRAINERD | CORPORATE DIRECTOR | — | 5/15/2019 | — |
| KATHERINE EDWARDS | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| KATHLEEN GIBSON | CORPORATE DIRECTOR | — | 5/20/2020 | — |
| KELBY HAGAR | CORPORATE DIRECTOR | — | 5/26/2021 | — |
| KELLEY NEWCOMER | OPERATIONAL/MANAGERIAL CONTROL | — | 7/21/2021 | — |
| KEVIN EDEN | CORPORATE OFFICER | — | 5/22/2024 | — |
| KEVIN EDEN | CORPORATE DIRECTOR | — | 9/17/2017 | — |
| LEVI DAVIS | CORPORATE OFFICER | — | 5/24/2023 | — |
| LUKE PAK | CORPORATE OFFICER | — | 5/22/2024 | — |
| LUKE PAK | CORPORATE DIRECTOR | — | 5/25/2022 | — |
| MARGARET BUCKLEY | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| MARK PORTER | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| MARK REISMAN | OPERATIONAL/MANAGERIAL CONTROL | — | 7/16/2024 | — |
| MATTHEW CRAFT | CORPORATE DIRECTOR | — | 5/26/2021 | — |
| MICHAEL CASEY | CORPORATE DIRECTOR | — | 5/26/2021 | — |
| MICHAEL PARRISH | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| MOSES VARGHESE | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| NANCY ROGERS | CORPORATE DIRECTOR | — | 5/22/2024 | — |
| NICOLETTE LAMONT | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| OLIVIA ROGERS | W-2 MANAGING EMPLOYEE | — | 8/1/2020 | — |
| OLIVIA ROGERS | OPERATIONAL/MANAGERIAL CONTROL | — | 4/19/2018 | — |
| ROBERT FINE | CORPORATE DIRECTOR | — | 5/25/2022 | — |
| SALLY DUTTER | CORPORATE DIRECTOR | — | 5/24/2023 | — |
| SONIA ROBINSON | OPERATIONAL/MANAGERIAL CONTROL | — | 7/1/2022 | — |
| STEPHANIE PHILLIPS | CORPORATE DIRECTOR | — | 5/21/2025 | — |
| YESENIA REYES | CORPORATE DIRECTOR | — | 5/25/2022 | — |
Source: CMS Hospice All Owners file, linked to this provider through its Medicare enrollment record. Medicare's Care Compare does not present ownership in this form.
Everything on this page is reproduced from the CMS Provider Data Catalog (July 2026 release) and, where shown, the CMS ownership and Medicare enrollment files. Nothing here is a rating or opinion of ours. If you believe a figure is wrong, email data@carerecords.org with the CCN and we verify against the official file within 5 business days.
How to cite this page: CareRecords, "Vna — hospice records, Dallas, TX." Compiled from the CMS Provider Data Catalog (July 2026 release), CCN 451506. https://carerecords.org/hospice/texas/vna-dallas/